Search tips
Search criteria 


Logo of skullbasesurgInstructions for AuthorsSubscribe to Skull BaseAbout Skull BaseEditorial BoardThieme Medical PublishingSkull Base An Interdisciplinary Approach ...
Skull base surgery. 1994 July; 4(3): 127–131.
PMCID: PMC1661798

Management of Unresectable Malignant Tumors at the Skull Base Using Concomitant Chemotherapy and Radiotherapy with Accelerated Fractionation


Between January 1988 and June 1992, 20 patients with unresectable malignant tumors at the skull base were treated. Eleven had T4 lesions of the paranasal sinus/cavity complex, and 9 had T4 nasopharynx cancer. All patients had stage IV disease by the American Joint Committee on Staging Criteria. The histology was squamous cell cancer in 15 patients and other minor salivary gland histologies in 5. There was brain and/or dural invasion in 11 patients and orbital invasion in 9. All patients received radiation therapy with accelerated fractionation to a total of 70 Gy in 6 weeks. Concomitant cisplatin (100 mg/m2) was given on days 1 and 22 of radiation. Seven patients received mitomycin C (7.5 mg/m2) on days 1 and 22, plus adjuvant chemotherapy with cisplatin and vinblastine. Median follow-up was 11 (range: 1 to 43) months. At 2 years, local progression-free survival was 94%, distant metastases-free survival was 57%, and overall survival was 80%. Complications occurred in 20% and caused the death of 1 patient. Treatment of this group of patients with aggressive chemotherapy and radiation therapy produced excellent local control in our early experience, but longer follow-up is needed. There is a high rate of distant failure. Future strategies are outlined.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (999K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Marcial VA. Ninth annual del Regato lecture: optimal multidisciplinary management of head and neck cancer. Int J Radiat Oncol Biol Phys. 1987 Mar;13(3):393–401. [PubMed]
  • Al-Sarraf M, Pajak TF, Marcial VA, Mowry P, Cooper JS, Stetz J, Ensley JF, Velez-Garcia E. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer. 1987 Jan 15;59(2):259–265. [PubMed]
  • Marcial VA, Pajak TF, Mohiuddin M, Cooper JS, al Sarraf M, Mowry PA, Curran W, Crissman J, Rodríguez M, Vélez-García E. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer. 1990 Nov 1;66(9):1861–1868. [PubMed]
  • Harrison LB, Pfister DG, Fass DE, Armstrong JG, Sessions RB, Shah JP, Spiro RH, Strong EW, Weisen S, Bosl GJ. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):703–708. [PubMed]
  • Weissberg JB, Son YH, Papac RJ, Sasaki C, Fischer DB, Lawrence R, Rockwell S, Sartorelli AC, Fischer JJ. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):3–9. [PubMed]
  • Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol. 1987 Sep;5(9):1410–1418. [PubMed]
  • Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian RL, Posner MR, Norris CM, Jr, Tuttle SA, Schoenfeld DA, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol. 1987 Jan;5(1):10–20. [PubMed]
  • Merlano M, Vitale V, Rosso R, Benasso M, Corvò R, Cavallari M, Sanguineti G, Bacigalupo A, Badellino F, Margarino G, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med. 1992 Oct 15;327(16):1115–1121. [PubMed]
  • Shah JP, Kraus DH, Arbit E, Galicich JH, Strong EW. Craniofacial resection for tumors involving the anterior skull base. Otolaryngol Head Neck Surg. 1992 Apr;106(4):387–393. [PubMed]
  • Jackson IT, Bailey MH, Marsh WR, Juhasz P. Results and prognosis following surgery for malignant tumors of the skull base. Head Neck. 1991 Mar-Apr;13(2):89–96. [PubMed]
  • Leitner SP, Bosl GJ, Strong EW, Gerold FP, Spiro RH, Shah JP, Sessions RB, Vikram B. A pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer. Cancer. 1986 Sep 1;58(5):1014–1017. [PubMed]
  • Kraus DH, Sterman BM, Levine HL, Wood BG, Tucker HM, Lavertu P. Factors influencing survival in ethmoid sinus cancer. Arch Otolaryngol Head Neck Surg. 1992 Apr;118(4):367–372. [PubMed]
  • Bedwinek JM, Perez CA, Keys DJ. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer. 1980 Jun 1;45(11):2725–2729. [PubMed]
  • Hoppe RT, Portlock CS, Glatstein E, Rosenberg SA, Kaplan HS. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease. Cancer. 1979 Feb;43(2):472–481. [PubMed]
  • Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys. 1981 Apr;7(4):447–453. [PubMed]
  • Hsu MM, Huang SC, Lynn TC, Hsieh T, Tu SM. The survival of patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 1982 May-Jun;90(3 Pt 1):289–295. [PubMed]
  • Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol. 1990 May;8(5):838–847. [PubMed]

Articles from Skull Base Surgery are provided here courtesy of Thieme Medical Publishers